Metabolomics Market Worth $2,100 Million by 2019 - New Report By MarketsandMarkets

The global metabolomics market is consolidated in nature, wherein the top five players account for more than 70%–75% of the market. http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketsandMarkets

MarketsandMarkets

Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Agilent Technologies (U.S.), Metabolon, Inc. (U.S.), Shimadzu Corporation (Japan), Bruker Corporation (U.S.), and Biocrates Life Sciences AG. (Austria)

(PRWEB) August 11, 2014

According to research report, the “Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication (Oncology, Cardiology) - Global Forecast to 2019” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.

Browse 80 market data tables and 7 figures spread through 270 slides and in-depth TOC on "Metabolomics Market."
http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html
Early buyers will receive 10% customization on this report.

In this report, the metabolomics market is segmented based on techniques, applications, indications, geographic regions, and countries. This report also discusses the key market drivers, restraints, and opportunities for this market and its sub-markets. The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019.

Download PDF brochure at http://www.marketsandmarkets.com/pdfdownload.asp?id=900.

The technological progress in biochemistry and molecular biology has played a significant role in the development of the metabolomics market during the last decade. Also, the improvements in analytical instruments, and data processing and analysis software have contributed significantly in the advancement of the metabolomics field. The presence of research funding and government support for conducting research and commercialization of the products in the metabolomics market is the primary driver for the growth of this market. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market. However, the lack of skilled professionals in metabolomics science is a significant restraint for the growth of the metabolomics market. The low adoption rate of metabolomics and data complexity are the other factors that are hindering the growth of the metabolomics market.

The global metabolomics market is poised to grow at a high CAGR of 30% from 2014 to 2019. The increase in government and private funding for metabolomics research and the growing demand for personalized medicine are some of the major factors driving the growth of the metabolomics market. Moreover, growth in the pharmaceutical and biotechnology industries is also expected to contribute to the growth of the metabolomics market during the forecast period of 2014 to 2019.

Download PDF brochure at http://www.marketsandmarkets.com/pdfdownload.asp?id=900.

In the techniques segment, high performance liquid chromatography (HPLC) accounted for the largest share of 38% of the global metabolomics market in 2014. The large share of this segment can be attributed to its wide application in biomarker discovery. The market is driven by the increase in research funding from governments and private investors in the metabolomics field.

Geographically, in 2014, the global metabolomics market was dominated by North America, primarily due to the presence of major metabolomics companies in the U.S. Increasing demand for personalized medicine is the major driver for this market in North America. By 2019, Europe will continue to dominate the market; the market share of this region is expected to increase to 49% by 2019 from 37% in 2014.

The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.).

Browse Related Reports

Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/molecular-spectroscopy-market-50034395.html

In-Vitro Toxicology Testing Market by Industry (Diagnostic, Pharmaceutical, Cosmetics, Chemical), Technology (Cell Culture, HTS, Omics), Applications (Systemic, Dermal, Ocular), Method (Cellular Assay, Ex vivo, In Silico) - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/in-vitro-toxicology-testing-market-209577065.html

About MarketsandMarkets:

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog at http://mnmblog.org/market-research/healthcare/biotechnology.
Connect with us on LinkedIn at http://www.linkedin.com/company/marketsandmarkets.


Contact